{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:02:53Z","timestamp":1792432973444,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UH3TR002151"],"award-info":[{"award-number":["UH3TR002151"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-2036197"],"award-info":[{"award-number":["DGE-2036197"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI155313"],"award-info":[{"award-number":["U01AI155313"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biomaterials.2024.122559","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T12:30:55Z","timestamp":1712233855000},"page":"122559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery"],"prefix":"10.1016","volume":"308","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7178-0097","authenticated-orcid":false,"given":"Yining","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-0391","authenticated-orcid":false,"given":"Shuting Sarah","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0831-6813","authenticated-orcid":false,"given":"Christine","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataes","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu Han","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-8143","authenticated-orcid":false,"given":"Charles","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9967-4758","authenticated-orcid":false,"given":"Ruochen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-8940","authenticated-orcid":false,"given":"Jiayuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2381-0607","authenticated-orcid":false,"given":"Shuming Alan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7990-199X","authenticated-orcid":false,"given":"Yeh-Hsing","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-4955","authenticated-orcid":false,"given":"Kam W.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-9988","authenticated-orcid":false,"given":"Hai-Quan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2024.122559_bib1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2024.122559_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2024.122559_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2024.122559_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2024.122559_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100450","article-title":"Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics","volume":"44","author":"Mukai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biomaterials.2024.122559_bib6","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biomaterials.2024.122559_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-023-01131-0","article-title":"Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity","author":"Zhu","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2024.122559_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2024.122559_bib9","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2024.122559_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425247.2012.673278","article-title":"Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery","volume":"9","author":"Battaglia","year":"2012","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2024.122559_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2174\/1389201021666200804155535","article-title":"Challenges in oral drug delivery and applications of lipid nanoparticles as potent oral drug carriers for managing cardiovascular risk factors","volume":"22","author":"Okur","year":"2021","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib12","first-page":"291","article-title":"Solid lipid nanoparticles in drug delivery","author":"Deshpande","year":"2017","journal-title":"Emerg. Nanotechnologies Diagnostics, Drug Deliv. Med. Devices, Elsevier"},{"key":"10.1016\/j.biomaterials.2024.122559_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.taap.2012.01.025","article-title":"A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice","volume":"260","author":"Walker","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/laban0512-129","article-title":"The effects of repeated oral gavage on the health of male CD-1 mice","volume":"41","author":"Arantes-Rodrigues","year":"2012","journal-title":"Lab Anim. (NY)."},{"key":"10.1016\/j.biomaterials.2024.122559_bib15","first-page":"805","article-title":"Evaluation of mice undergoing serial oral gavage while awake or anesthetized","volume":"55","author":"Jones","year":"2016","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.biomaterials.2024.122559_bib16","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2024.122559_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.574474","article-title":"Genetics of familial hypercholesterolemia: new insights","volume":"11","author":"Vrablik","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.biomaterials.2024.122559_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tibs.2008.06.005","article-title":"PCSK9 and LDL cholesterol: unravelling the target to design the bullet","volume":"33","author":"Costet","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biomaterials.2024.122559_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2018.06.859","article-title":"Familial hypercholesterolemia treatments: guidelines and new therapies","volume":"277","author":"Raal","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biomaterials.2024.122559_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jacl.2018.04.002","article-title":"Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: a model that explores the efficacy of conventional and novel lipid-lowering therapy","volume":"12","author":"Hartgers","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.hfc.2021.07.008","article-title":"New frontiers in the treatment of homozygous familial hypercholesterolemia","volume":"18","author":"Cesaro","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.biomaterials.2024.122559_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ejmech.2015.01.022","article-title":"LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153\u2013421): design, synthesis and biochemical evaluation","volume":"92","author":"Alghamdi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2024.122559_bib24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11883-022-01057-z","article-title":"Expanding biology of PCSK9: roles in atherosclerosis and beyond","volume":"24","author":"Seidah","year":"2022","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.biomaterials.2024.122559_bib26","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jacc.2019.03.517","article-title":"Low LDL cholesterol by PCSK9 variation reduces cardiovascular mortality","volume":"73","author":"Benn","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrcardio.2017.91","article-title":"ANGPTL3: a therapeutic target for atherosclerosis","volume":"14","author":"Lim","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1253\/circj.CJ-18-0442","article-title":"ANGPTL3 inhibitors \u2015 their role in cardiovascular disease through regulation of lipid metabolism","volume":"83","author":"Geladari","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.biomaterials.2024.122559_bib29","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.3390\/ijms22147310","article-title":"Angiopoietin-like protein 3 (ANGPTL3) modulates lipoprotein metabolism and dyslipidemia","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2024.122559_bib30","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.2174\/0929867326666190621120523","article-title":"Structure and function of angiopoietin-like protein 3 (ANGPTL3) in atherosclerosis","volume":"27","author":"Lu","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biomaterials.2024.122559_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11883-022-01071-1","article-title":"ANGPTL3 as a drug target in hyperlipidemia and atherosclerosis","volume":"24","author":"Mohamed","year":"2022","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.biomaterials.2024.122559_bib32","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2024.122559_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature13902","article-title":"In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR\/Cas9 system","volume":"516","author":"Maddalo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2024.122559_bib34","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biomaterials.2024.122559_bib35","first-page":"236","article-title":"Machine learning elucidates design features of plasmid DNA lipid nanoparticles for cell type-preferential transfection","volume":"125","author":"Cheng","year":"2023","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40259-019-00399-6","article-title":"Small interfering RNA therapeutic inclisiran: a new approach to targeting PCSK9","volume":"34","author":"German","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.biomaterials.2024.122559_bib37","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.3390\/jcm11226773","article-title":"Recent advances in gene therapy for familial hypercholesterolemia: an update review","volume":"11","author":"Fu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biomaterials.2024.122559_bib38","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2024.122559_bib39","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1093\/eurheartj\/ehaa689","article-title":"Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia","volume":"41","author":"Gaudet","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biomaterials.2024.122559_bib40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.122.059266","article-title":"Effect of vupanorsen on non\u2013high-density lipoprotein cholesterol levels in statin-treated patients with elevated cholesterol: TRANSLATE-TIMI 70","volume":"145","author":"Bergmark","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2024.122559_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/jcm12010168","article-title":"Evinacumab, an ANGPTL3 inhibitor, in the treatment of dyslipidemia","volume":"12","author":"Sosnowska","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biomaterials.2024.122559_bib42","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/ATVBAHA.120.315204","article-title":"ANGPTL3 inhibition with evinacumab results in faster clearance of IDL and LDL apoB in patients with homozygous familial hypercholesterolemia\u2014brief report","volume":"41","author":"Reeskamp","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biomaterials.2024.122559_bib43","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2024.122559_bib44","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-023-37465-1","article-title":"GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy","volume":"14","author":"Kasiewicz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2024.122559_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actbio.2018.09.047","article-title":"Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery","volume":"81","author":"He","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2024.122559_bib46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/acs.nanolett.2c02306","article-title":"Phenylboronic acid-functionalized polyplexes tailored to oral CRISPR delivery","volume":"23","author":"Yoshinaga","year":"2023","journal-title":"Nano Lett."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:30:02Z","timestamp":1750102202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"alternative-id":["S0142961224000930"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122559","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122559"}}